These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38589934)

  • 1. Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process.
    Jennings LK; Lander L; Lawdahl T; McClure EA; Moreland A; McCauley JL; Haynes L; Matheson T; Jones R; Robey TE; Kawasaki S; Moschella P; Raheemullah A; Miller S; Gregovich G; Waltman D; Brady KT; Barth KS
    Addict Sci Clin Pract; 2024 Apr; 19(1):26. PubMed ID: 38589934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal screening for substance use by Peer Support Specialists in the Emergency Department is a pathway to buprenorphine treatment.
    Gertner AK; Roberts KE; Bowen G; Pearson BL; Jordan R
    Addict Behav Rep; 2021 Dec; 14():100378. PubMed ID: 34938837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs.
    Sue KL; Chawarski M; Curry L; McNeil R; Coupet E; Schwartz RP; Wilder C; Tsui JI; Hawk KF; D'Onofrio G; O'Connor PG; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2023 May; 6(5):e2312718. PubMed ID: 37163263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
    Shulman M; Weiss R; Rotrosen J; Novo P; Costello E; Nunes EV
    Addict Sci Clin Pract; 2021 Mar; 16(1):15. PubMed ID: 33676577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary report of knowledge translation: lessons from taking screening and brief intervention techniques from the research setting into regional systems of care.
    Bernstein E; Topp D; Shaw E; Girard C; Pressman K; Woolcock E; Bernstein J
    Acad Emerg Med; 2009 Nov; 16(11):1225-33. PubMed ID: 20053242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
    Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
    Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
    Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
    Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
    Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
    Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study.
    McCormack RP; Rotrosen J; Gauthier P; D'Onofrio G; Fiellin DA; Marsch LA; Novo P; Liu D; Edelman EJ; Farkas S; Matthews AG; Mulatya C; Salazar D; Wolff J; Knight R; Goodman W; Hawk K
    Addict Sci Clin Pract; 2021 Mar; 16(1):16. PubMed ID: 33750454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of a Peer-Navigator Program on Naloxone Distribution and Buprenorphine Utilization in the Emergency Department.
    Ramdin C; Guo M; Fabricant S; Santos C; Nelson L
    Subst Use Misuse; 2022; 57(4):581-587. PubMed ID: 34970942
    [No Abstract]   [Full Text] [Related]  

  • 14. Retention in Treatment after Emergency Department-Initiated Buprenorphine.
    Jennings LK; Lane S; McCauley J; Moreland A; Hartwell K; Haynes L; Barth KS; Gainey SS; Brady KT
    J Emerg Med; 2021 Sep; 61(3):211-221. PubMed ID: 34176686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.
    Hu T; Snider-Adler M; Nijmeh L; Pyle A
    CJEM; 2019 Jul; 21(4):492-498. PubMed ID: 31006398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency department interventions for opioid use disorder: A synthesis of emerging models.
    Thomas CP; Stewart MT; Tschampl C; Sennaar K; Schwartz D; Dey J
    J Subst Abuse Treat; 2022 Oct; 141():108837. PubMed ID: 35841743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and attitudes reported by Canadian emergency physicians regarding the initiation of buprenorphine/naloxone in the emergency department for patients with opioid use disorder.
    Savage T; Ross M
    CJEM; 2022 Jan; 24(1):44-49. PubMed ID: 34564838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study.
    Badke K; Small SS; Pratt M; Lockington J; Gurney L; Kestler A; Moe J
    BMC Health Serv Res; 2024 Feb; 24(1):211. PubMed ID: 38360620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.
    Holland WC; Nath B; Li F; Maciejewski K; Paek H; Dziura J; Rajeevan H; Lu CC; Katsovich L; D'Onofrio G; Melnick ER
    Acad Emerg Med; 2020 Aug; 27(8):753-763. PubMed ID: 32352206
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.